Fundraising Fox.png){kind=icon}
Capital Rx
also invests · investor profileNew York, US · 12 known investors
Find your way into Capital Rx
Sign up to see every warm intro you have to Capital Rx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Capital Rx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Judi Rx (formerly Capital Rx) is a transparent, fiduciary-aligned pharmacy benefits manager that prices drugs against the federal NADAC benchmark, passes through rebates, and charges a single flat administrative fee. It serves employers, labor unions, health plans, and brokers, and runs on the cloud-based Judi platform alongside Judi Care for unified pharmacy and medical benefits administration.
Founders & leadership
Board
LM
JK
KH
Kevin HillBoard director
RM
DD
Daniel DelmastroBoard director
FA
Feby AbrahamBoard director
Investors · 12
.jpeg){kind=logo}
B Capital Grouplisted by B Capital GroupSan Francisco · $10M – $50M
How we know: the VCSheet dataset · Not right? Tell us
TRANSFORMATION CAPITALlisted by TRANSFORMATION CAPITALBoston
How we know: TRANSFORMATION CAPITAL's portfolio page · board seat on SEC Form D · prnewswire.com · Not right? Tell us
Wellington Managementlisted by Wellington ManagementBoston · $5M – $50M
How we know: prnewswire.com · wellington.com · Not right? Tell us
B Capitalreported
How we know: prnewswire.com · Not right? Tell us
Edison PartnersreportedNashville · $5M – $25Mvia Lenard Marcus · board
How we know: board seat on SEC Form D · prnewswire.com · Not right? Tell us
.png)
Also in the syndicate · 2
Growth Equity at Goldman Sachs AlternativesPrime Health Investments
Reported raises · per SEC filings
Form D private placements$499.6M disclosed across 6 rounds · 2019–2025
▶$230.8MraisedSep 2025 · 8 investors · OtherRule 506(b)
▶$230.8MraisedSep 2025 · 8 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Jared KesselheimDirector
- Mark KandrysawtzDirector
- Lenard MarcusDirector
- Ryan KellyDirector
- Robert MittendorffDirector
- Kevin HillDirector
- Holly MaloneyDirector
- Mostafa KamalDirector
- A. J. LoiaconoExecutive Officer, Director
- Daniel DelmastroDirector
- Offering amount
- $232.9M
- Amount sold
- $230.8M
- First sale
- Aug 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$115MraisedMar 2024 · 1 investors · OtherRule 506(b)
▶$115MraisedMar 2024 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Lenard MarcusDirector
- Jared KesselheimDirector
- Ryan KellyDirector
- Kevin HillDirector
- A. J. LoiaconoDirector, Executive Officer
- Robert MittendorffDirector
- Feby AbrahamDirector
- Daniel DelmastroDirector
- Offering amount
- $312.5M
- Amount sold
- $115M
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$106MraisedJun 2022 · 9 investors · OtherRule 506(b)
▶$106MraisedJun 2022 · 9 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Jared KesselheimDirector
- Laleh AlemzadehExecutive Officer
- Ryan KellyDirector
- Robert MittendorffDirector
- Joseph AlexanderExecutive Officer
- Kevin HillDirector
- A. J. LoiaconoExecutive Officer, Director
- Lenard MarcusDirector
- Offering amount
- $106M
- Amount sold
- $106M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$3.5MraisedJul 2021 · 4 investors · OtherRule 506(b)
▶$3.5MraisedJul 2021 · 4 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Ryan KellyDirector
- Joseph AlexanderExecutive Officer, Director
- Lenard MarcusDirector
- A. J. LoiaconoExecutive Officer, Director
- Kevin HillDirector
- Jared KesselheimDirector
- Laleh AlemzadehExecutive Officer
- Offering amount
- $3.5M
- Amount sold
- $3.5M
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$32MraisedJan 2021 · 4 investors · OtherRule 506(b)
▶$32MraisedJan 2021 · 4 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Ryan KellyDirector
- A. J. LoiaconoExecutive Officer, Director
- Lenard MarcusDirector
- Laura AlemzadehExecutive Officer
- Kevin HillDirector
- Jared KesselheimDirector
- Joseph AlexanderExecutive Officer, Director
- Offering amount
- $53M
- Amount sold
- $32M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$12.4MraisedJul 2019 · 1 investors · OtherRule 506(b)
▶$12.4MraisedJul 2019 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- A.J. LoiaconoExecutive Officer, Director
- Ryan KellyDirector
- Joseph AlexanderDirector
- Lenard MarcusDirector
- Offering amount
- $16.4M
- Amount sold
- $12.4M
- Minimum investment
- $16.4M
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Capital Rx do?
- Judi Rx (formerly Capital Rx) is a transparent, fiduciary-aligned pharmacy benefits manager that prices drugs against the federal NADAC benchmark, passes through rebates, and charges a single flat administrative fee. It serves employers, labor unions, health plans, and brokers, and runs on the cloud-based Judi platform alongside Judi Care for unified pharmacy and medical benefits administration.
- Who founded Capital Rx?
- Capital Rx was founded by AJ Loiacono, Ryan Kelly, A. J. Loiacono.
- Who are Capital Rx's investors?
- Capital Rx's investors include B Capital Group, B4 Capital, Koru Capital, TRANSFORMATION CAPITAL, Wellington Management, 9Yards Capital, B Capital, Edison Partners and 2 more.
- How much funding has Capital Rx raised?
- Capital Rx has disclosed $499.6M raised across 6 rounds.
- Where is Capital Rx headquartered?
- Capital Rx is headquartered in New York, US.